SPYRE THERAPEUTICS, INC. (SYRE)
Clinical trial NCT06672718 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-22 → 2026-08-19 3. primary completion date: 2026-02-18 → 2026-08-19 4. enrollment: 56 → 50 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical